Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
pipeline
Biotech
Kronos shelves sole clinical drug over neurological side effects
The clock is ticking for Kronos Bio after the biotech discontinued its last remaining clinical-stage asset over neurological adverse events.
James Waldron
Nov 14, 2024 5:14am
Bayer drops Huntington's gene therapy
Nov 12, 2024 10:09am
ADC Therapeutics axes lead solid tumor drug after phase 1 blow
Nov 7, 2024 8:24am
Sarepta axes late-phase DMD drug over safety signal, FDA talks
Nov 7, 2024 7:45am
Genmab axes 3 programs to focus on plumped-up pivotal pipeline
Nov 7, 2024 5:41am
Cellectis drops one of its 3 clinical-stage CAR-Ts
Nov 5, 2024 7:15am
